Highbridge Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-13,656	Closed	-$1.6M	–	1612
2017 Q3	$1.6M	Buy	+13,656	New	+$1.17M	0.04%	478
2016 Q4	–	Sell	-6,447	Closed	-$437K	–	1227
2016 Q3	$437K	Buy	+6,447	New	+$455K	0.01%	843
2016 Q2	–	Sell	-89,786	Closed	-$5.64M	–	1374
2016 Q1	$5.64M	Buy	+89,786	New	+$5.97M	0.12%	247
2015 Q3	–	Sell	-29,500	Closed	-$3.54M	–	1502
2015 Q2	$3.54M	Sell	29,500 -905	-3%	-$108K	0.06%	373
2015 Q1	$3.17M	Buy	+30,405	New	+$3.08M	0.05%	420
2014 Q2	–	Sell	-5,240	Closed	-$352K	–	1042
2014 Q1	$352K	Buy	5,240 +700	+15%	+$54.2K	0.01%	795
2013 Q4	$292K	Buy	+4,540	New	+$271K	﹤0.01%	851
2013 Q3	–	Sell	-6,718	Closed	-$335K	–	1253
2013 Q2	$209K	Buy	+6,718	New	+$179K	﹤0.01%	1169